Please try another search
For the six months ended 30 June 2019, Biodue SpA revenues increased 3% to EUR21.6M. Net income decreased 7% to EUR1.6M. Revenues reflect Italy segment increase of 6% to EUR19M. Net income was offset by Other Service Costs increase of 15% to EUR4.5M (expense), Depreciation increase of 22% to EUR982K (expense). Basic Earnings per Share excluding Extraordinary Items decreased from EUR0.16 to EUR0.15.
Period Ending: | Jun 30, 2019 | Dec 31, 2018 | Jun 30, 2018 | Dec 31, 2017 |
---|---|---|---|---|
Total Revenue | 21.55 | 20.12 | 20.89 | 17.31 |
Gross Profit | 12.38 | 11.71 | 11.96 | 9.17 |
Operating Income | 1.85 | 2.8 | 2.55 | 1.42 |
Net Income | 1.64 | 2.23 | 1.76 | 2.9 |
Period Ending: | Jun 30, 2019 | Dec 31, 2018 | Jun 30, 2018 | Dec 31, 2017 |
---|---|---|---|---|
Total Assets | 51.12 | 47.26 | 43.52 | 37.8 |
Total Liabilities | 28.94 | 25.87 | 24 | 19.31 |
Total Equity | 22.17 | 21.39 | 19.53 | 18.49 |
Period Ending: | Jun 30, 2019 | Dec 31, 2018 | Jun 30, 2018 | Dec 31, 2017 |
---|---|---|---|---|
Period Length: | 6 Months | 12 Months | 6 Months | 12 Months |
Cash From Operating Activities | 0.7 | 4.38 | 1.32 | 2.39 |
Cash From Investing Activities | -3.65 | -7.42 | -4.04 | -2.7 |
Cash From Financing Activities | 0.98 | 5.54 | 2.83 | 0.58 |
Net Change in Cash | -1.97 | 2.49 | 0.11 | 0.27 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review